Patent · US Active

Onychomycosis treatment compositions and methods

US11400061B2 · kind B2 · utility

0Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2021
Grant dateAug 2, 2022
Priority date
Expiry dateSep 14, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are presented that provide substantially improved physical and pharmacological parameters for subungually administrable formulations. Most beneficially, the compositions presented herein have a viscosity and film-forming capacity that retain the liquid formulation in sufficient quantities and that help penetrate the polysaccharide matrix commonly associated with onychomycosis. In especially preferred aspects, the carrier is formulated to have a high concentration of the active pharmaceutically active agent (API), to allow migration of the formulation within the subungual space, and to reduce systemic absorption while promoting diffusion of the API into the nail plate at or above minimum inhibitory concentration into a larger treatment space.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.